Homburger advises Thermo Fisher on 1bn Swiss francs bond issuance
The American supplier of analytical instruments, Thermo Fisher Scientific, with annual revenues of close to US$50 billion, has successfully completed the issuance of its inaugural Swiss franc bonds. It is reportedly the largest foreign Swiss franc bond issuance in seven years, with a total value of more than 1 billion Swiss francs. The issuance consisted of three tranches, the CHF 330m 1.6525% bonds due 2028, the CHF 415m 1.8401% bonds due 2032 and the CHF 325m 2.0375% bonds due 2036.
The bonds are governed by Swiss law and have been provisionally admitted to trading. An application has been made for definitive admission to trading and listing of the bonds on the SIX Swiss Exchange. The investment banks that acted as lead managers were UBS, BNP Paribas (Suisse), and Deutsche Bank.
Homburger advised Thermo Fisher Scientific with respect to all legal, transactional and tax aspects of Swiss law. The Homburger team was led by Benjamin Leisinger (pictured) and included Daniel Hulmann, both Capital Markets, as well as Stefan Oesterhelt, Tax.
